RegisterLogin

PH-064

CAT: 0804-HY-10499-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-10499-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
PH-064 (BIM-46187) is an orally active inhibitor of the heterotrimeric G-protein complex. PH-064 inhibits SERT activity and attenuates shear stress-induced Akt phosphorylation. PH-064 has potent anti-hyperalgesia activity. PH-064 inhibits G protein-coupled receptor-dependent tumorigenesis. PH-064 can be used in the study of pain (e.g., inflammatory pain, neuropathic pain), GPCR-dependent tumors, and inflammatory lung injury[1][2][3][4][5][6].
CAS Number
[892546-37-1]
Product Name Alternative
BIM-46187
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Akt; Serotonin Transporter
Type
Reference compound
Related Pathways
Neuronal Signaling; PI3K/Akt/mTOR
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/PH-064.html
Purity
99.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C([C@H](CSSC[C@@H](C(N1CCN2C([C@@H]1CC3CCCCC3)=NC(C4=CC=CC=C4)=C2)=O)N)N)N([C@H]5CC6CCCCC6)CCN(C5=N7)C=C7C8=CC=CC=C8
Molecular Formula
C44H58N8O2S2
Molecular Weight
795.11
Precautions
H302, H315, H319, H335
References & Citations
[1]Favre-Guilmard C, et al. The novel inhibitor of the heterotrimeric G-protein complex, BIM-46187, elicits anti-hyperalgesic properties and synergizes with morphine. Eur J Pharmacol. 2008 Oct 10;594 (1-3) :70-6.|[2]Dela Paz NG, et al. Rapid flow-induced activation of Gαq/11 is independent of Piezo1 activation. Am J Physiol Cell Physiol. 2019 May 1;316 (5) :C741-C752. |[3]Haase J, et al. Sex and brain region-specific regulation of serotonin transporter activity in synaptosomes in guanine nucleotide-binding protein G (q) alpha knockout mice. J Neurochem. 2021 Oct;159 (1) :156-171.|[4]Auguet M, et al. SYNERGISTIC ANALGESIC INTERACTION BETWEEN MORPHINE AND BIM‐46187. European Journal of Pain, 2006, 10 (S1) : S89-S89. |[5]Silvente-Poirot S, et al. Heterotrimeric G-protein inhibitor BIM-46187 inhibits G-protein coupled receptor dependent tumorigenesis in athymic mice. Cancer Research, 2007, 67 (9_Supplement) : 5603-5603. |[6]Joshi JC, et al. RGS2 is an innate immune checkpoint for suppressing Gαq-mediated IFNγ generation and lung injury. iScience. 2025 Jan 27;28 (2) :111878.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-149026-01GNE-064
HY-114965-01TP-064
HY-175602TM-04-064-02
HY-144121Ph-Ph+
HY-133463Tetrazine-Ph-PEG5-Ph-tetrazine
HY-133465Tetrazine-Ph-PEG4-Ph-aldehyde
HY-179667APH calibration buffer, pH 7.00
HY-179667PH calibration buffer, pH 4.01
HY-179667BPH calibration buffer, pH 10.01
HY-151797Ph-HTBA

Alternative Products

CatalogName
M24916-01PH-064
A21659-5PH-064 5mg
A21659-25PH-064 25mg
A21659-50PH-064 50mg
A21659-10PH-064 10mg
A21659-100PH-064 100mg
C01470-01TP-064
BA4693-50GNE-064

Popular Products